Stryker Corporation (SYK)
Healthcare
Medical Devices
325.70 $
-6.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Stryker Corporation (SYK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.7% of the shares are freely tradable; institutional investors hold 82.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
82.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
5.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
90.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
1.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
383Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 8.84 | 33,907,291 | +0.4 | 12/31/2025 |
| BlackRock Inc | 7.20 | 27,602,049 | +0.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 5.84 | 22,383,181 | +0.0 | 03/31/2026 |
| Greenleaf Trust | 4.16 | 15,938,070 | -3.8 | 03/31/2026 |
| JPMorgan Chase & Co | 4.07 | 15,596,897 | +28.4 | 03/31/2026 |
| State Street Corp | 4.00 | 15,349,165 | +0.6 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 2.62 | 10,037,137 | -0.8 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.17 | 8,334,244 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.86 | 10,975,262 | +0.3 | 04/30/2026 |
| Vanguard 500 Index Investor | 2.33 | 8,931,170 | +1.8 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.